Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001012035 | SCV001172435 | pathogenic | Hereditary cancer-predisposing syndrome | 2019-11-22 | criteria provided, single submitter | clinical testing | The c.1531_1532delAA pathogenic mutation, located in coding exon 13 of the MRE11A gene, results from a deletion of two nucleotides at nucleotide positions 1531 to 1532, causing a translational frameshift with a predicted alternate stop codon (p.N511Yfs*2). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Cancer Genomics Group, |
RCV004794475 | SCV005045662 | likely pathogenic | Hereditary breast ovarian cancer syndrome | 2023-03-27 | criteria provided, single submitter | research |